Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 54.60K | 31.90K | 24.00K | 27.40K | 20.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.60K | 31.90K | 24.00K | 27.40K | 20.70K |
| Cost of Revenue | 53.60K | 38.00K | 29.20K | 65.50K | 55.50K |
| Gross Profit | 1.00K | -6.20K | -5.20K | -38.20K | -34.80K |
| SG&A Expenses | 160.60K | 160.50K | 237.20K | 231.10K | 290.10K |
| Depreciation & Amortization | -- | 3.10K | -1.20K | 1.00K | 800.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.20K | 201.60K | 265.20K | 297.60K | 346.40K |
| Operating Income | -159.50K | -169.70K | -241.20K | -270.30K | -325.70K |
| Income Before Tax | -193.90K | -147.30K | -676.50K | -275.40K | -331.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -193.90K | -147.30K | -676.50K | -275.40K | -331.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -193.90K | -147.30K | -676.50K | -275.40K | -331.80K |
| EBIT | -159.50K | -169.70K | -241.20K | -270.30K | -325.70K |
| EBITDA | -153.10K | -158.20K | -218.80K | -237.70K | -295.40K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 104.87M | 101.29M | 101.29M | 101.29M | 101.29M |
| Average Diluted Shares Outstanding | 104.87M | 101.29M | 101.29M | 101.29M | 101.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |